Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.

Also called NCT07648693

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Resonova (Shanghai) Medtech Limited (from the registry)
Registry
  • NCT NCT07648693
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07648693. Randomized; no masking; primary purpose prevention. Start 2025-10-31 (actual); primary completion 2026-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial
Condition
Cerebral Vascular Accident (CVA)/Stroke
Intervention (Device)
CHORDS® Cerebral Protection System
Intervention (Device)
Sentinel Cerebral Protection System
Lead sponsor
Resonova (Shanghai) Medtech Limited (class: industry)

Record details

Record id
cardio:ct-nct07648693
Content hash
dd7d1228fa0aeb2097b3121adad6c7eb7995e8a6ed33175a9c25dcd04cf04b4b